Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

T. Burkard, C. A. Kaiser, H. Brunner-La Rocca, S. Osswald, M. E. Pfisterer, R. V. Jeger*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Web of Science)
Original languageEnglish
Pages (from-to)257-263
JournalJournal of Internal Medicine
Issue number3
Publication statusPublished - Mar 2012


  • antiplatelet therapy
  • coronary artery disease
  • myocardial infarction
  • percutaneous coronary intervention

Cite this